Trending stocks: Ajanta Pharma shares rise 4.31%

The stock quoted a 52-week high of Rs 1536.5 and a 52-week low of Rs 825.

Getty Images
Ajanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 12015.00 crore) operating in the Pharmaceuticals sector.
NEW DELHI: Shares of Ajanta Pharma traded 4.31 per cent up in Wednesday's trade at 11:43 am. Around 1,11,259 shares changed hands on the counter. The stock opened at Rs 1425.0 and touched an intraday high and low of Rs 1460.0 and Rs 1403.75, respectively, in the session so far.

Ajanta Pharma got USFDA nod for Metformin Hydrochloride tablets.

The stock quoted a 52-week high of Rs 1536.5 and a 52-week low of Rs 825.


Financials
Ajanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 12015.00 crore) operating in the Pharmaceuticals sector.

The company reported net profit after tax of Rs 107.55 crore for the quarter ended 31 December, 2019. For the same quarter, the company has reported Consolidated sales of Rs 651.21 crore, up 1.31 per cent from last quarter Sales of Rs 642.76 crore and up 34.24 per cent from last year same quarter Sales of Rs 485.11 crore.

ADVERTISEMENT
Ajanta Pharma key products/revenue segments include pharmaceutical products which contributed Rs 1762.69 crore to sales value (96.29 per cent of total sales), export incentives which contributed Rs 66.17 crore to sales value (3.61 per cent of total sales) and other operating revenue which contributed Rs 1.59 crore to sales value (0.08 per cent of total sales)for the year ending 31-mar-2018.

Promoter holding
Promoters held 70.51077 per cent stake in the company as of quarter ended 31st Dec 2019.

Valuation ratio
It quoted a price-to-earnings ratio of 29.37 and price to book value of 5.59.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Trending stocks: Ajanta Pharma shares rise 4.31%
Text Size:AAA
Success
This article has been saved

*

+